Healwell AI Inc. (TSX:AIDX)
Canada · Delayed Price · Currency is CAD | Market Cap | 234.54M -36.1% |
| Revenue (ttm) | 128.74M +135.3% |
| Net Income | -29.62M |
| EPS | -0.10 |
| Shares Out | 304.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 250,257 |
| Open | 0.8000 |
| Previous Close | 0.7700 |
| Day's Range | 0.7700 - 0.8100 |
| 52-Week Range | 0.5800 - 1.6100 |
| Beta | -0.96 |
| Analysts | Strong Buy |
| Price Target | 1.84 (+132.91%) |
| Earnings Date | Nov 6, 2026 |
About Healwell AI
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also... [Read more]
Financial Performance
In 2025, Healwell AI's revenue was 103.80 million, an increase of 426.62% compared to the previous year's 19.71 million. Losses were -47.11 million, 79.2% more than in 2024.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for AIDX stock is "Strong Buy." The 12-month stock price target is $1.84, which is an increase of 132.91% from the latest price.
News
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN™ AI as a globally recognized heal...
Healwell AI price target lowered to C$1.50 from C$2 at Alliance Global
Alliance Global analyst Brian Kinstlinger lowered the firm’s price target on Healwell AI (HWAIF) to C$1.50 from C$2 and keeps a Buy rating on the shares following the Q2 report.
Healwell AI Earnings Call Transcript: Q2 2026
Q2 2026 revenue was CAD 33 million, flat year-over-year, with positive adjusted EBITDA and strong operating cash flow. The business is transitioning to recurring enterprise sales, with robust AI adoption and a healthy pipeline, targeting a 10% adjusted EBITDA margin by year-end.
Healwell AI Earnings release: Q2 2026
Healwell AI released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
HEALWELL Achieves Revenue of $33 Million, Improved Operating Cash Flow and a Strengthened Balance Sheet in Q2-2026
HEALWELL achieved revenue from continuing operations of $33.0 million in Q2-2026 compared to revenue of $33.2 million in Q2-2025. Revenue remained consistent with the prior year, as one-time professio...
HEALWELL AI Announces Conference Call for Second Quarter 2026 Financial Results on August 7, 2026
HEALWELL AI to hold a conference call and simultaneous webcast on Friday, August 7, 2026, at 8:30 am ET (5:30 am PT). Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - HEALWELL AI Inc. (TSX: AIDX)...
Healwell AI price target raised to C$2 from C$1.50 at Scotiabank
Scotiabank raised the firm’s price target on Healwell AI (HWAIF) to C$2 from C$1.50 and keeps an Outperform rating on the shares.
HEALWELL AI Announces Voting Results of 2026 AGSM
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative ca...
HEALWELL AI Provides Corporate Update: Multi-Province AI Pilot Results Accepted at AMIA Symposium; Alongside Balance Sheet Strengthening with SpaceX Holdings
HEALWELL successfully completed a pilot evaluating its DARWEN™ AI powered SMART Summary™ and SMART Search™ solutions in multiple provinces across Canada. The pilot demonstrated how clinically validate...
Healwell AI price target lowered to C$2 from C$2.25 at Alliance Global
Alliance Global analyst Brian Kinstlinger lowered the firm’s price target on Healwell AI (HWAIF) to C$2 from C$2.25 and keeps a Buy rating on the shares. The firm updated the…
Healwell AI Earnings Call Transcript: Q1 2026
Q1 2026 saw revenue surge 316% year-over-year to CAD 33.2 million, driven by the Orion Health acquisition and organic AI growth, with positive adjusted EBITDA and improved margins. The company is focused on scaling globally, leveraging strong public sector tailwinds and a robust pipeline across AI and Healthcare Software.
Healwell AI Earnings release: Q1 2026
Healwell AI released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Healwell AI Registration statement: Q1 2026
Healwell AI filed a registration statement on May 8, 2026, providing details about a securities offering with the SEC.
Healwell AI Registration statement: Q1 2026
Healwell AI filed a registration statement on May 8, 2026, providing details about a securities offering with the SEC.
HEALWELL Delivers 316% Revenue Growth and Increasing Customer Traction in Q1-2026
HEALWELL achieved quarterly revenue from continuing operations of $33.2 million in Q1-2026, an increase of 316% compared to revenue of $8.0 million generated in Q1-2025. Revenue growth in the quarter ...
HEALWELL AI Announces Conference Call for First Quarter 2026 Financial Results on May 8, 2026
HEALWELL AI to hold a conference call and simultaneous webcast on Friday, May 8, 2026, at 8:30 am ET (5:30 am PT). Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - HEALWELL AI Inc. (TSX: AIDX) (O...
HEALWELL AI Appoints Brad Porter to Board of Directors
HEALWELL appoints Brad Porter, Chief Commercial Officer of HEALWELL and CEO of Orion Health, to its Board of Directors to strengthen the Company's commercial and strategic expertise. Ian McCrae is ste...
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
2026 Bloom Burton & Co. Healthcare Investor Conference on April 21-22, 2026, in Toronto, ON Toronto, Ontario--(Newsfile Corp. - April 13, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL...
Healwell AI initiated with a Buy at TD Securities
TD Securities initiated coverage of Healwell AI (HWAIF) with a Buy rating and C$1.75 price target The firm believes shares are poised to continue the rebound from their recent 52-week…
Healwell AI price target lowered to C$2.50 from C$3 at Raymond James
Raymond James analyst Michael Freeman lowered the firm’s price target on Healwell AI (HWAIF) to C$2.50 from C$3 and keeps an Outperform rating on the shares.
Healwell AI price target lowered to C$2.50 from C$3.10 at Stifel
Stifel lowered the firm’s price target on Healwell AI (HWAIF) to C$2.50 from C$3.10 and keeps a Buy rating on the shares.
Healwell AI Earnings Call Transcript: Q4 2025
Revenue surged 427% to CAD 103.8M in 2025, driven by Orion Health acquisition and global expansion, with first positive Adjusted EBITDA achieved. AI and software segments both saw rapid growth, and the company targets 50% AI revenue growth and a 10% EBITDA margin in 2026.
Healwell AI Earnings release: Q4 2025
Healwell AI released its Q4 2025 earnings on March 20, 2026, summarizing the period's financial results.
Healwell AI Registration statement: Q4 2025
Healwell AI filed a registration statement on March 20, 2026, providing details about a securities offering with the SEC.
Healwell AI Registration statement: Q4 2025
Healwell AI filed a registration statement on March 20, 2026, providing details about a securities offering with the SEC.